The countdown has begun!
In just a few minutes, the Global Virtual Symposium on Liquid Biopsy 2026 will officially begin, bringing together an exceptional lineup of internationally renowned scientists, clinicians, researchers, and industry innovators to explore the latest breakthroughs in liquid biopsy, precision oncology, and cancer diagnostics.
Over the course of this scientific symposium, attendees will gain insights into the rapidly evolving landscape of liquid biopsy, including its applications in early cancer detection, minimal residual disease (MRD), circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), DNA methylation, gene fusion detection, point-of-care diagnostics, and personalized cancer treatment.
The symposium features an outstanding panel of global experts, including Prof. Klaus Pantel, Catherine Alix-Panabières, Valerie Taly, Sven Borchmann, Leonora Balaj, Stefano Cinti, Milana Frenkel-Morgenstern, Prof. Dr. med. Georg Weber, Remond Fijneman, Melanie Janning, Dr. Jürgen Scheuenpflug, and many other distinguished leaders who continue to shape the future of precision medicine.
This event offers a unique opportunity to hear directly from pioneers whose research is driving the translation of innovative laboratory discoveries into real-world clinical applications that improve cancer diagnosis, treatment monitoring, and patient outcomes.
Whether you’re a researcher, clinician, healthcare professional, student, or industry expert, this symposium promises an afternoon of cutting-edge science, meaningful discussions, and valuable networking with the global liquid biopsy community.
We’re going live in just a few minutes!
Stay tuned as we bring you live updates, key scientific highlights, and expert insights throughout the event.
Join the symposium:
https://liquidbio.ircconferences.net/
We look forward to welcoming you to an inspiring day dedicated to advancing the future of cancer diagnostics and precision oncology.
